Seattle Alzheimer ’s drug developer Athira Pharma aims to raise $170M in IPO

Athira Pharma will try to raise upwards of $170 million in its initial public offering this year, according to documents filed with the U.S. Securities and Exchange Commission on Monday. On Aug. 26, the company filed that it was planning an IPO later this year. In Monday’s filing the company said it will offer 10 million shares of common stock at a price between $15 and $17 per share. Potentially another 1.5 million shares will be offered at those prices. The IPO would suppor t the company’s…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news